Logo

John Ryan, Buzz Sztukowski, Douglas Dolginow

Sep 05, 2006
Premium
Expression Analysis has appointed the following people to its scientific advisory board: John Ryan, chief medical officer of AVEO Pharmaceuticals; Richard Hockett, medical fellow and director of genomic medicine at Eli Lilly; and Buzz Sztukowski, senior vice president of global marketing and strategic development at BioMerieux.
 
 
Gene Logic said Aug. 16 that Douglas Dolginow has left the company. Dolginow was senior vice president of pharmacogenomics. He will continue to be employed by Gene Logic on a part-time basis as a fellow and senior advisor.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.